Strategic Blueprint’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.27M Buy
3,013
+1,536
+104% +$612K 0.06% 265
2026
Q2
$535K Buy
1,477
+202
+16% +$69.1K 0.03% 445
2026
Q1
$449K Sell
1,275
-99
-7% -$35.3K 0.03% 434
2025
Q4
$450K Sell
1,374
-7,306
-84% -$2.32M 0.03% 423
2025
Q3
$2.45M Buy
8,680
+325
+4% +$94.3K 0.11% 180
2025
Q2
$2.33M Buy
8,355
+1,349
+19% +$382K 0.11% 173
2025
Q1
$2.18M Buy
7,006
+819
+13% +$242K 0.12% 165
2024
Q4
$1.61M Buy
6,187
+136
+2% +$40.4K 0.1% 184
2024
Q3
$1.95M Buy
6,051
+71
+1% +$23.2K 0.12% 157
2024
Q2
$1.87M Buy
5,980
+171
+3% +$50.2K 0.13% 154
2024
Q1
$1.65M Buy
5,809
+209
+4% +$61.2K 0.12% 170
2023
Q4
$1.61M Buy
5,600
+55
+1% +$15K 0.13% 157
2023
Q3
$1.49M Buy
5,545
+52
+0.9% +$13K 0.14% 152
2023
Q2
$1.22M Sell
5,493
-466
-8% -$108K 0.12% 167
2023
Q1
$1.44M Buy
5,959
+378
+7% +$92.8K 0.15% 148
2022
Q4
$1.47M Sell
5,581
-6
-0.1% -$1.61K 0.17% 140
2022
Q3
$1.26M Buy
5,587
+52
+0.9% +$12.6K 0.15% 148
2022
Q2
$1.35M Buy
+5,535
New +$1.36M 0.17% 138
2021
Q3
– Sell
-177
Closed -$43K – 437
2021
Q2
$43K Buy
+177
New +$43.5K 0.01% 655
2021
Q1
– Sell
-9,412
Closed -$2.16M – 298
2020
Q4
$2.16M Buy
+9,412
New +$2.17M 0.54% 47
2019
Q4
– Sell
-234
Closed -$45K – 108
2019
Q3
$45K Buy
+234
New +$44.9K 0.03% 163

Other funds holding AMGN

Strategic Blueprint's AMGN Position: Q3 2026 in Review

Strategic Blueprint increased its Amgen (AMGN) stake by 104% in Q3 2026, buying an estimated $612K and bringing the position to 3,013 shares worth $1.27M. The position accounts for 0.06% of the portfolio, ranked #265.

Strategic Blueprint first reported a position in AMGN in Q3 2019 and has held it in 21 quarters since. The position peaked at $2.45M in Q3 2025. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Strategic Blueprint held 3,013 shares of Amgen worth $1.27M as of Q3 2026.
  • Strategic Blueprint bought 1,536 Amgen shares in Q3 2026, an estimated $612K.
  • Amgen made up 0.06% of Strategic Blueprint's portfolio in Q3 2026, its #265 holding.
  • Strategic Blueprint first reported a position in Amgen in Q3 2019 and has held it in 21 quarters since.
  • Strategic Blueprint's Amgen position peaked at $2.45M in Q3 2025.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Strategic Blueprint's 13F filing for Q3 2026, filed 22 Oct 2026.